Chapter title |
An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy
|
---|---|
Chapter number | 1 |
Book title |
Duchenne Muscular Dystrophy
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7374-3_1 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7373-6, 978-1-4939-7374-3
|
Authors |
Jean K. Mah |
Abstract |
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in childhood. Mutations of the DMD gene destabilize the dystrophin associated glycoprotein complex in the sarcolemma. Ongoing mechanical stress leads to unregulated influx of calcium ions into the sarcoplasm, with activation of proteases, release of proinflammatory cytokines, and mitochondrial dysfunction. Cumulative damage and reparative failure leads to progressive muscle necrosis, fibrosis, and fatty replacement. Although there is presently no cure for DMD, scientific advances have led to many potential disease-modifying treatments, including dystrophin replacement therapies, upregulation of compensatory proteins, anti-inflammatory agents, and other cellular targets. Recently approved therapies include ataluren for stop codon read-through and eteplirsen for exon 51 skipping of eligible individuals. The purpose of this chapter is to summarize the clinical features of DMD, to describe current outcome measures used in clinical studies, and to highlight new emerging therapies for affected individuals. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 56 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 16% |
Student > Bachelor | 7 | 13% |
Other | 6 | 11% |
Researcher | 4 | 7% |
Student > Postgraduate | 3 | 5% |
Other | 9 | 16% |
Unknown | 18 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 20% |
Nursing and Health Professions | 7 | 13% |
Biochemistry, Genetics and Molecular Biology | 7 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 5 | 9% |
Unknown | 21 | 38% |